DALLAS, TX--(Marketwire - November 12, 2007) - Veramyst™ (fluticasone furoate) Nasal Spray demonstrated significant improvement in the treatment of nasal and ocular allergy symptoms of perennial allergic rhinitis (PAR) in patients 12 years of age and older, according to a clinical study presented at the annual scientific meeting of the American College of Allergy, Asthma & Immunology (ACAAI).
